Carolyn Sueprofile image

Carolyn Sue AM

Current Appointments

Kinghorn Chair, Neurodegeneration
email hidden; JavaScript is required

Professor Carolyn Sue, MBBS, PhD, FRACP, is an internationally recognised clinician-scientist, a leader in Parkinson’s and mitochondrial disease and a medicine alum of UNSW who trained at Prince of Wales Hospital and at Columbia University in the United States.

Professor Sue was the head of the Departments of Neurogenetics and Neurology at Northern Sydney Local Health District, while also leading Royal North Shore Hospital’s clinic for Mitochondrial disease patients – the largest Mitochondrial disease clinic in Australia. She is the immediate past Executive Director of the Kolling Institute, where she positioned the institute as a centre of world-leading translational research excellence.

Carolyn’s experience, expertise and contribution have been widely recognised. She is a Fellow of the Australian Academy of Health and Medical Sciences and serves on the Council of the National Health and Medical Research Council. She also holds leadership roles at Movement Disorder Society of Australia and New Zealand, International Parkinson’s disease and Movement Disorder Society, the Mito Foundation and Australian Mitochondrial Disease Medical Network. In 2019, Carolyn was awarded a member of the Order of Australia (AM) in recognition of her significant services to medicine, particularly mitochondrial disease.


2023, 03 Jan

Author Response: Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

View full journal-article on

2022 Jul

Decompensation of cardiorespiratory function and emergence of anemia during pregnancy in a case of mitochondrial myopathy, lactic acidosis, and sideroblastic anemia 2 with compound heterozygous YARS2 pathogenic variants

View full journal-article on

2022, 21 Mar

Mitochondrial donation: is Australia ready?

View full journal-article on

2022 Mar

The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease

View full journal-article on

2022 Jan

Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations

View full journal-article on

2021, 11 Nov

NEMoE: A nutrition aware regularized mixture of experts model addressing diet-cohort heterogeneity of gut microbiota in Parkinson’s disease

View full preprint on

Donate to us

Every dollar of community support enables our scientists to continue making life-changing discoveries that contribute to a brighter and healthier future.


Fundraise for us

Run, swim or bake your way to making a positive difference in the lives of people touched by brain and nervous system disorders.

Get involved